COVID-19 cardiovascular epidemiology, cellular pathogenesis, clinical manifestations and management.
Int J Cardiol Heart Vasc
; 29: 100589, 2020 Aug.
Article
in English
| MEDLINE | ID: covidwho-642152
ABSTRACT
Coronavirus Disease 2019 (COVID-19) is a rapidly progressing global pandemic that may present with a variety of cardiac manifestations including, but not limited to, myocardial injury, myocardial infarction, arrhythmias, heart failure, cardiomyopathy, shock, thromboembolism, and cardiac arrest. These cardiovascular effects are worse in patients who have pre-existing cardiac conditions such as coronary artery disease, hypertension, diabetes mellitus, and coagulation abnormalities. Other predisposing risk factors include advanced age, immunocompromised state, and underlying systemic inflammatory conditions. Here we review the cellular pathophysiology, clinical manifestations and treatment modalities of the cardiac manifestations seen in patients with COVID-19.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Type of study:
Observational study
/
Prognostic study
Language:
English
Journal:
Int J Cardiol Heart Vasc
Year:
2020
Document Type:
Article
Affiliation country:
J.ijcha.2020.100589
Similar
MEDLINE
...
LILACS
LIS